China Immunotech
Changping · Founded 2018
About China Immunotech
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2022)
- Website: http://www.cn-immunotech.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/china-immunotech-18689 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.